COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20200411047029N1


Column Value
Trial registration number IRCT20200411047029N1
Full text link
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

hamidreza shekhroshandel

Contact
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

info@taamasrar.com

Registration date
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2021-04-24

Recruitment status
Last imported at : May 21, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

multi-center

Study aim
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Age more than 18 years Definite diagnosis of SARS-CoV-2 virus based on PCR Diagnosis of pneumonia consistent with lung involvement with COVID-19 on CT scan Need to be admitted to the ICU at the beginning of hospitalization

Exclusion criteria
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Having comorbidities (chronic kidney failure, cirrhosis, severe heart failure (less than 25% EF), active or untreated cancer) Pregnancy and breastfeeding Patients with hepatic enzymes including aspartate transaminase (AST) and alanine transaminase (ALT) at 5 times more than normal amount

Number of arms
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

The Research Institute of Food and Secrets TAAMASRAR

Inclusion age min
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

100

Countries
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Critical disease at enrollment

Severity scale
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

8: Critical disease at enrollment

Total sample size
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

198

primary outcome
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Duration and severity of symptoms (cough and shortness of breath) Duration of hospitalization Blood oxygen levels Requirement for ICU admission Duration of hospitalization in the ICU Death rate

Notes
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 3

Arms
Last imported at : April 25, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 2339, "treatment_name": "Phr-160", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]